NextFin News - The artificial intelligence investment cycle has reached a precarious inflection point where corporate exuberance is beginning to signal future market exhaustion. GMO, the Boston-based asset manager known for its value-driven skepticism, has moved to short the equity markets of South Korea and Taiwan within its systematic global macro strategy. The firm’s pivot, revealed on March 24, 2026, marks a significant bet against the two primary Asian engines of the global semiconductor supply chain, which have seen their valuations stretched by a historic surge in capital expenditure.
The rationale behind the move rests on a historical correlation between aggressive corporate investment and subsequent equity underperformance. Martin Emery, a portfolio strategist for GMO’s systematic global macro team, noted that the current AI buildout mirrors past cycles where overconfidence led to overinvestment, eventually resulting in lower earnings surprises and recessions. While the broader market remains captivated by the "hyperscaler" spending spree, GMO’s models suggest that the very intensity of this spending is a harbinger of diminishing returns. The firm’s positioning is now defined by a stark spread: long the United States, but short U.S. technology, South Korea, and Taiwan.
The scale of the rally preceding this short position provides context for the contrarian stance. Over the past twelve months, South Korean and Taiwanese equities have surged 127% and 66% respectively in U.S. dollar terms. This performance was driven almost entirely by a handful of index heavyweights—Samsung Electronics, SK Hynix, and Taiwan Semiconductor Manufacturing Company (TSMC)—which have become the de facto proxies for global AI infrastructure. However, GMO’s analysis indicates that these markets are now fundamentally expensive, with long-term value forecasts falling below the prevailing cash rate.
Beyond simple valuation metrics, GMO is tracking the sentiment of corporate leadership as a contrarian indicator. Emery pointed to the "extremely positive" tone of recent earnings calls from major cloud providers and tech giants. Historical data suggests that when CEO confidence peaks and triggers massive capital outlays, the market often enters a phase of "investment growth" that precedes a sharp correction in total returns. For the systematic macro strategy, which avoids direct stock picking in favor of broad market exposures, the current environment justifies a "quite short" stance on equities globally.
The risk for GMO lies in the duration of the AI "supercycle." If the productivity gains from generative AI materialize faster than the capital is consumed, the anticipated recessionary pressure could be deferred, leaving short sellers exposed to further momentum-driven gains. Yet, the firm’s systematic approach is betting on the mean reversion of capital cycles. By shorting the hardware-heavy markets of Seoul and Taipei, GMO is positioning for a reality where the physical buildout of AI finally outpaces the immediate economic utility, leading to a painful recalibration for the world’s most vital chipmakers.
Explore more exclusive insights at nextfin.ai.
